Navigation Links
Alzheimer's Drug Development Summit: CBI to Donate Portion of This Week's Proceeds to the Alzheimer's Association
Date:9/21/2009

WOBURN, Mass., Sept. 21 /PRNewswire/ -- The Center for Business Intelligence (CBI) announced today that they will donate a portion of the proceeds from their Alzheimer's Drug Development Summit to the Alzheimer's Association. CBI will donate $100 for every registration completed this week, September 21-25, 2009, in recognition of World Alzheimer's Day.

World Alzheimer's Day joins Alzheimer's associations, globally, to raise awareness and encourage citizens to take action against the disease. CBI is committed to developing forums that unite industry thought leaders in the field of Alzheimer's research and drug development. "By putting together cutting-edge forums and supporting the Alzheimer's Association, we're proud to be doing our part on this very important day," said Michelle DeMunbrun, Program Manager at CBI. "Every little bit counts, and with all of our collective efforts, it's only a matter of time before we establish a cure for this devastating disease."

The annual Alzheimer's Summit, in its third year, will be chaired by Ronald Black, M.D., Assistant Vice President, Neuroscience, Wyeth. The conference will take place in Arlington, VA, on December 8-9, 2009. Day-two case study, "Addressing the Two Most Challenging Aspects of Alzheimer's Clinical Trials -- Accelerating Patient Recruitment and Reducing Drop-Out Rates" will be a highlight at this timely and pertinent event. In addition to five other case studies and an extended panel discussion, attendees will have multiple opportunities to network with industry colleagues.

Top neuroscience and drug development executives from companies such as Eisai, Alzheimer's Association, The Critical Path Institute, Elan Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Wyeth and The National Institute on Aging will explore how to:

  • Examine targeting protein kinases and the unique challenges associated with CNS drug discovery
  • Discuss whether disease modifying therapeutics can show symptomatic benefits
  • Assess whether the AD drug candidates, to date, failed the clinical trials or the clinical trials failed the drugs
  • Gain a better understanding of AB trafficking and the peripheral sink hypothesis
  • Learn the potential role of MRI and PET imaging in biomarkers in facilitating Alzheimer's disease drug development
  • Examine the implications of ADNI data for use of neuroimaging and fluid biomarkers in clinical trials for Alzheimer's disease
  • Discuss the integration of a mobile clinical network into an Alzheimer's clinical trial to meet sponsor and investigator deliverables and objectives

The conference brings together key researchers and stakeholders to examine the latest symptomatic and disease modifying approaches for the clinical development of new AD therapies. For more information on the conference or to view the agenda, please visit http://www.cbinet.com/alzheimers.

About CBI:

A subsidiary of Advanstar Communications, The Center for Business Intelligence is dedicated to developing market-driven, unbiased conferences in the pharmaceutical, biotechnology, and medical device industries. For more information, please visit http://www.cbinet.com.

For additional information or media inquiries, please contact: Emily Forest, Marketing Manager, at 339-298-2156.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE The Center for Business Intelligence
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT
2. Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
5. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
6. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
7. Global Experts Explore Entire Spectrum of Aids Vaccine Development
8. Vical Names Andrew de Guttadauro Vice President, Corporate Development
9. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
10. SemBioSys updates Apo AI development program
11. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... ... and traumatic injuries, will be accelerated by research at Worcester Polytechnic Institute (WPI) ... of wound healing and tissue regeneration. , The novel method, developed by WPI ...
(Date:5/23/2016)... Antonio, Texas (PRWEB) , ... May 23, 2016 , ... The need for blood donations ... released this week by the South Texas Blood & Tissue Center, blood donations are on ... than 30 years, and they are down 21 percent in South Texas in the last ...
(Date:5/23/2016)... LONDON , May 23, 2016 ... Efficiency by 40% - Frontage Implement a Single Platform ... Quality, Compliance and Traceability Within the Bioanalytical lab Frontage ... the United States and China ... across its laboratory facilities. In addition to serving as the global ...
(Date:5/20/2016)... , ... May 20, 2016 , ... The leading Regenerative ... its most experienced veterinary clients have treated over 100 of their own patients with ... to provide the highest level of care for their patients. , The veterinarians ...
Breaking Biology Technology:
(Date:3/18/2016)... --> --> Competitive Landscape Analysis ... Physical infrastructure and Perimeter Surveillance & Detection Systems ... and the continuing migration crisis in the Middle ... led visiongain to publish this unique report, which is crucial ... & security companies in the border security market and the ...
(Date:3/15/2016)... , March 15, 2016 --> ... published by Transparency Market Research "Digital Door Lock Systems Market ... 2015 - 2023," the global digital door lock systems market ... in 2014 and is forecast to grow at a CAGR ... micro, small and medium enterprises (MSMEs) across the world and ...
(Date:3/14/2016)... NXTD ) ("NXT-ID" or the "Company"), a company ... of a new series of commercials on Time Warner Cable ... .  The commercials will air on Bloomberg TV, Fox Business ... show. --> NXTD ) ("NXT-ID" or the "Company"), ... the airing of a new series of commercials on Time ...
Breaking Biology News(10 mins):